Therapeutic Potential of Tauroursodeoxycholic Acid for the Treatment of Osteoporosis

Tauroursodeoxycholic acid (TUDCA) is a US FDA-approved hydrophilic bile acid for the treatment of chronic cholestatic liver disease. In the present study, we investigate the effects of TUDCA on the proliferation and differentiation of osteoblasts and its therapeutic effect on a mice model of osteopo...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahn, Tae-Keun, Kim, Kyoung-Tae, Joshi, Hari Prasad, Park, Kwang Hwan, Kyung, Jae Won, Choi, Un-Yong, Sohn, Seil, Sheen, Seung-Hun, Shin, Dong-Eun, Lee, Soo-Hong, Han, In-Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7349164/
https://www.ncbi.nlm.nih.gov/pubmed/32560070
http://dx.doi.org/10.3390/ijms21124274

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7349164/
https://www.ncbi.nlm.nih.gov/pubmed/32560070
http://dx.doi.org/10.3390/ijms21124274

Ejemplares similares